SignalDailyGlobal signals. Global context.

Market Incident

Public · Developing

AI compiled from Infoway · 4 analyzed stories

Onconetix, Inc. (ONCO) Sets 1-for-10 Reverse Split Effective Nov. 6

Onconetix approved a 1-for-10 reverse stock split effective 12:01 a.m. ET on Nov. 6, 2026, cutting outstanding shares from about 5,886,774 to about 588,677. Shares keep trading on Nasdaq under ONCO, with a new CUSIP 68237Q500.

Published:

Updated:

What happened

Onconetix's board approved a one-for-ten reverse stock split. The company said it expects the split to take effect at 12:01 a.m. ET on November 6, 2026. Outstanding shares will drop from about 5,886,774 to about 588,677. Shares will keep trading on Nasdaq under ONCO, with a new CUSIP 68237Q500.

Global impact / market context

In a reverse split, a company combines several existing shares into one. Shareholders end up with fewer shares, and each share is meant to represent a higher price. The company's total value is not changed by the split itself. For ordinary investors, the main practical effects are fewer shares in the account and a different share price.

What to watch

  1. Check that the split actually takes effect on November 6, 2026, as stated, because a delay would change when share counts and prices adjust.
  2. Check the new CUSIP, 68237Q500, because it identifies the post-split shares and helps confirm the change was applied correctly.
  3. Check that ONCO still trades on Nasdaq after the split, because the company said the listing symbol stays the same.

Affected assets

  • Onconetix, Inc. Common Stock

Evidence